Endometriosis Cedip

ENDOMETRIOSIS ROL DEL TRATAMIENTO MÉDICO Y QUIRURGICO Dr. Max Araneda Residente Ginecología- Obstetricia.

ENDOMETRIOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

ENDOMETRIOSIS ,[object Object],[object Object],[object Object],Ginecología Novak, 12° ed,1997,cap26; 887-914

ENDOMETRIOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object],Clinical Gynecologic Endocrinology and Infertility,Speroff, 6° ed, 1999, p 1057-73.

[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],ENDOMETRIOSIS

PATOGÉNESIS ,[object Object],[object Object],[object Object]

METAPLASIA CELÓMICA ,[object Object],[object Object],[object Object]

TEORÍA DE IMPLANTACIÓN ,[object Object],ENDOMETRIOSIS

TEORÍA DE IMPLANTACIÓN ,[object Object],[object Object],[object Object],[object Object]

FACTORES ASOCIADOS ,[object Object],[object Object],[object Object],[object Object],[object Object]

FACTOR ANATÓMICO ,[object Object],[object Object],[object Object]

FACTOR GENÉTICO ,[object Object],[object Object],[object Object],[object Object],[object Object]

FACTOR HORMONAL ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

FACTOR INMUNOLÓGICO ,[object Object],[object Object],[object Object],[object Object],[object Object]

FACTOR PERITONEAL ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

MECANISMOS PROTECTORES ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

VÍAS DE DISEMINACIÓN ,[object Object],[object Object],[object Object],[object Object]

TIPOS DE ENDOMETRIOSIS ,[object Object],[object Object],[object Object],[object Object],[object Object]

TIPOS DE ENDOMETRIOSIS ,[object Object],[object Object],[object Object],[object Object]

[object Object],[object Object],[object Object],[object Object],TIPOS DE ENDOMETRIOSIS

LOCALIZACIÓN ANATÓMICA 44 34 34 31 25,3 21,4 20,9 15,4 Ovario Izquierdo Fondo Saco post. Fondo Saco ant. Ovario Derecho Lig. Ancho Izq. Lig. Ancho Der. Lig. Uterosacro I. Lig. Uterosacro D. %

POSIBLES MECANISMOS DE INFERTILIDAD ,[object Object],[object Object],[object Object],[object Object]

Trata m iento ,[object Object],[object Object],[object Object],[object Object],[object Object]

Tratamiento ,[object Object]

Tratamiento Quirúrgico ,[object Object],[object Object],[object Object]

Tratamiento Quirúrgico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Tratamiento Quirúrgico ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Tratamiento Quirúrgico de las Lesiones Mínimas ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

Tratamiento Quirúrgico de las Lesiones Mínimas . ,[object Object],[object Object],[object Object],[object Object]

Resultado tratamiento Quirúrgico ,[object Object],[object Object],[object Object],[object Object],[object Object]

Resultado Tratamiento Quirúrgico ,[object Object],[object Object],[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],Lessey, Bruce A. Medical management of endometriosis and infertility. Fertility and Sterility June 2000;73(6):1089-1096.

OBJETIVOS DEL TRATAMIENTO ,[object Object],[object Object],[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object],Leuprolide (Lupron Depot) amp 3,75-7,5 mg Treptorrelina (Decapeptyl) amp 3,75 mg Nafarelina Buserelina Danogar cap 200 mg (x 50 cap) A.M.P. comp 5-10 mg (x 20 comp) Depo-prodasone amp 150 mg (x 1) 20  g e.e

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],Vercellini P.,Ragni G. Does contraception modify the risk of endometriosis?. Hum Reprod 1993;8:547-51

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object],Hull M.E., Comparison of different treatment modalities of endometriosis in infertile women, Fertil Steril 47:40,1987.

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],Tellima S, Danazol and medroxyprogesterone acetate inefficacious in the treatment of infertility in endometriosis, Fertil Steril 50:872,1988

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],Barbieri R.L,Danazol inhibition of steroidogenesis in the human corpus luteum, Obstet Gynecol 57:722,1981.

TRATAMIENTO MÉDICO ,[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object]

GnRH-a APLICACIONES CLINICAS ,[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],Välimäki M, Comparison between the effects of Nafarelin and Danazol on serum lipids and lipoproteins in patients with endometriosis, J Clin Endocrinol Metab 69:1097,1989.

RESPUESTA ENDOMETRIAL ,[object Object],[object Object],[object Object],[object Object]

METABOLISMO OSEO ,[object Object],[object Object],[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],Hezl M.R.,Gonadotropin-realising analogs: update on new findings Am J Obstet Gynecol 166:757,1992.

ESTRATEGIAS DE TRATAMIENTO PARA MANEJO DE EFECTOS COLATERALES ,[object Object],[object Object],[object Object]

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Taskin O, Effectiveness of tibolone on hypoestrogenic symptoms induced by goserelintreatment in patients with endometriosis, Fertil Steril 67:40,1997.

TRATAMIENTO MÉDICO ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Lessey, Bruce A. Medical management of endometriosis and infertility. Fertility and Sterility June 2000;73(6):1089-1096.

RECURRENCIA ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],Waller K.,GnRh analogues for the treatment of endometriosis; long term follow-up, Fertil steril 59:511,1993.

RECURRENCIA ,[object Object],[object Object],[object Object],Wheeler J, Recurrent endometriosis: incidence management and prognosis, Am J Obstet Gynecol 146:247,1993.

CONCLUSIONES ,[object Object],[object Object],[object Object]

CONCLUSIONES ,[object Object],[object Object],[object Object],[object Object]

Endometriosis Cedip

Recomendados

Recomendados

Más contenido relacionado

La actualidad más candente

La actualidad más candente (20)

Destacado

Destacado (20)

Similar a Endometriosis Cedip

Similar a Endometriosis Cedip (20)

Más de gatitamony

Más de gatitamony (19)

Último

Último (20)

Endometriosis Cedip